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See related article on page 54.doi:10.1016/j.jtcvs.2005.09.007Robotics has been used in numerous surgical procedures, but with fewexceptions, this technologic advance has not been translated into improvedoutcomes. Many robotic applications have been unveiled as the manifesta-
tion a new idea in search of an application. The principal advantages of robotic
assistance in surgical intervention are the greater degree of instrumental articulation
and motion scaling.1 However, despite these recognized technical advantages, the
demonstration of superior results has been disappointing.
A significant clinical application for surgical robotics has been for resection of
prostate cancer. In a prospective nonrandomized trial comparing robotic with
conventional radical retropubic prostatectomy among 60 patients, Menon and col-
leaguesr2 found that the robotic approach significantly reduced intraoperative blood
loss and postoperative pain compared with the open approach. Furthermore, although
the mean length of stay for patients in the conventional group was 4 days, two thirds
of men undergoing robotic prostatectomy were discharged in less than 23 hours.
Robotic mitral valve surgery is also gaining acceptance, although there are no
randomized studies that demonstrate superiority compared with the conventional
approaches. In a recently published prospective series of 38 consecutive patients,
Nifong and associates3 reported no operative deaths, strokes, or conversions to open
sternotomy. The average total operative time was less than 5 hours, and the mean
length of stay was 4 days.3 In a recent phase II multicenter trial of robotic mitral
valve surgery, total robot, aortic crossclamp, and cardiopulmonary bypass times
were 78 minutes, 2.1 hours, and 2.8 hours, respectively. At 1 month of transthoracic
echocardiography, only 8% had grade 2 mitral regurgitation. There were no deaths,
strokes, or device-related complications.4
The use of robotics is also being studied in general thoracic surgery, including
lobectomy,5 esophagectomy,6 and various other procedures,7 demonstrating safety
and feasibility. The study by Park and coworkers8 in this issue of the Journal
describes their experience in developing a standardized approach to robotic lobec-
tomy. As with most thoracic procedures that can be performed robotically, the
potential advantages of articulation in 7 degrees and motion stability are probably
not fully realized in robotic lobectomy. The growing experience with thoracoscopic
lobectomy suggests that the limitations imposed by the thoracoscopic technique,
such as port placement and visualization, are easily overcome.9,10
However, there are several disadvantage of the robotic system. One important
disadvantage is the loss of tactile sense in current systems. Although thoracoscopic
lobectomy might alter tactile feedback compared with open thoracotomy, much infor-
mation is nevertheless communicated to the surgeon’s hands. The significance of
this feedback is difficult to quantify, and it is possible that robotic systems will be
designed to transmit tactile information in the future.
In addition, the instrumentation that is available for use robotically is limited in
comparison with the instrumentation available for thoracoscopic or open lobectomy.
It is unlikely that the same spectrum of instrumentation will be developed for the
robot. Perhaps the superior articulation of the robotic system will compensate for the
inferior selection of instrumentation.
Also, the time required to assemble the robotic instrumentation is significant, as
is the increase in the overall operative time. In this study the median operative time
was 218 minutes, and the median room time was 306 minutes.8 Although the total
operative times are likely to decrease with experience, as they have with thoraco-





Lscopic lobectomy,9,10 the mandatory set-up time seems pro-
hibitive for most surgeons.
Currently, the robotic technique appears to require 3
experienced surgeons8 compared with 1 for the thoraco-
scopic technique.9,10 In the short term this will negatively
affect resident training at institutions that favor the robotic
approach. In addition, the introduction of robotic and other
technology into the operating room has necessitated the
development of training programs to teach surgeons how to
use the technology. It will be important for surgeons to dem-
onstrate mastery of these techniques before including them in
practice.
In summary, the analysis by Park and coworkers8 is an
important and commendable effort to study and standardize
the robotic technique. The outcomes of the robotic tech-
nique should be compared with thoracoscopic techniques,
which are associated with significant advantages vis a vis
thoracotomy, including shorter length of stay, less pain,
preserved pulmonary function, and faster return to full ac-
tivity.9,10 As experience with robotic lobectomy improves,
the disadvantages might become less important, and the
advantages might become more well defined. Although it is
not likely that a randomized study would be funded to
compare robotic lobectomy with alternatives, some ap-
praisal must be made to assess overall effectiveness, includ-
ing cost-effectiveness. Surgeons who study technologic ad-
vances, such as robotic lobectomy, will be better prepared to
20 The Journal of Thoracic and Cardiovascular Surgery ● Januaadapt, to lead the field, to develop more effective tech-
niques, and to improve surgical outcomes.1
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